BRIEF-Biocept reports agreement with Teneovita Medical

Tue Aug 30, 2016 8:29am EDT
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article
[-] Text [+]

Aug 30 (Reuters) - Biocept Inc :

* Biocept announces agreement with Teneovita Medical to market and distribute its Liquid Biopsy testing platform in Canada

* Preferred provider agreement with Teneovita Medical, a division of Teneovita Medical Innovations Inc. Source text for Eikon: Further company coverage: